Semax: ACTH-Derived Neuropeptide — BDNF Upregulation and 5 Cognitive Parameters Studied
Semax is a synthetic heptapeptide derived from the ACTH 4-10 fragment that enhances cognitive function, provides neuroprotection, and upregulates brain-derived neurotrophic factor (BDNF) through interaction with melanocortin receptors and dopaminergic/serotonergic pathways in the central nervous system.
Semax was developed in Russia in the 1980s and has been used clinically there for decades in the context of stroke recovery, neurological conditions, and cognitive enhancement. Its research base is more extensive than most Western peptide practitioners acknowledge, with documented effects on BDNF (the brain's primary neuroplasticity-supporting protein), serotonin and dopamine receptor sensitivity, HIF-1 (hypoxia-inducible factor 1), and anti-oxidant enzyme activity.
At Rebuild Regen Medical Clinic, Semax is prescribed for patients with cognitive fatigue, reduced mental clarity, stress-related performance decline, neuropathic conditions requiring nerve regeneration support, or neurological recovery goals.
What Semax Is — ACTH 4-10 Fragment and Neuropeptide Mechanisms
ACTH (adrenocorticotropic hormone) is primarily known for its role in cortisol production. Its 4-10 fragment (amino acids 4 through 10) has cognitive and neuroprotective effects that are independent of the adrenal axis — it does not stimulate cortisol release. Semax is a modified, stabilized version of this fragment with extended activity.
Primary mechanisms:
BDNF upregulation: Brain-derived neurotrophic factor is the primary signal for neuronal survival, synaptic plasticity, and learning. Semax significantly upregulates BDNF in the hippocampus and cortex — regions central to memory, learning, and emotional regulation. This is its most consistently documented mechanism and the basis for its use in neurodegenerative and neuropathic contexts.
Dopaminergic and serotonergic modulation: Semax enhances sensitivity at dopamine and serotonin receptor subtypes, supporting motivation, mood stability, and cognitive processing speed.
Neuroprotective effects: Semax reduces oxidative stress in neural tissue through upregulation of antioxidant enzymes (superoxide dismutase, catalase). It also activates HIF-1, which supports neuronal survival under conditions of ischemia or oxidative challenge.
Anti-fatigue and stress adaptation: Semax has documented effects on reducing cognitive and physical fatigue under stress conditions, likely mediated by its effects on monoaminergic neurotransmitter systems.
Clinical Applications
Cognitive enhancement: Mental clarity, focus, and information processing speed. Patients with high-demand cognitive workloads or cognitive fatigue from stress, poor sleep, or aging describe noticeable improvements within days to weeks.
Neuropathy support: Semax's BDNF-upregulating and neuroprotective properties make it a useful adjunct in neuropathy treatment protocols at Rebuild Regen. It supports nerve fiber survival and regeneration from the neuroplasticity side while other modalities address the inflammatory and metabolic root causes.
Post-illness cognitive recovery: Patients with post-COVID cognitive symptoms (brain fog, processing speed reduction, memory complaints) are candidates for Semax protocols directed at neuroinflammation reduction and BDNF restoration.
Stress adaptation: High-performance professionals, athletes during overtraining periods, or patients going through significant life stress who experience cognitive degradation use Semax for its adaptogenic neurological effects.
Administration
Semax is administered intranasally (nasal spray) — the intranasal route provides direct access to the olfactory epithelium and bypasses the blood-brain barrier challenge that makes many neuropeptides difficult to deliver systemically. This is one of Semax's practical advantages: no injection required for most protocols.
Standard dosing is 200 to 900 mcg intranasally daily, typically administered in the morning. Cycles of 2 to 4 weeks are common, followed by a break period. Elizabeth designs the cycle structure based on the clinical indication.
Frequently Asked Questions
Is Semax available in the United States?
Semax is available in the United States as a compounded peptide from FDA-registered compounding pharmacies. It is not FDA-approved for any specific indication. Elizabeth prescribes it within her clinical scope for patients with appropriate clinical indications.
How quickly does Semax work?
Semax is among the fastest-acting peptides in clinical use for cognitive applications. Many patients notice effects on mental clarity and focus within the first few days of intranasal use. BDNF-mediated effects on neuroplasticity accumulate over weeks of consistent use.
Can Semax be combined with Selank?
Semax and Selank are frequently combined in clinical practice. Semax provides cognitive activation and BDNF support; Selank provides anxiolytic, anti-fatigue, and cognitive calming effects. The combination produces cognitive enhancement with reduced anxiety — a common goal for high-performance applications. Elizabeth designs the combination based on the patient's specific cognitive profile.
When Semax Is Not Appropriate
Semax is not appropriate as a substitute for addressing underlying causes of cognitive decline (thyroid dysfunction, sleep apnea, hormonal deficiency, depression requiring treatment). It does not address structural neurodegeneration. Patients with active seizure disorders should be evaluated carefully before any CNS-active peptide is prescribed. Elizabeth reviews the full clinical picture before prescribing.
Rebuild Regen Medical Clinic 3320 N Federal Hwy #101, Lighthouse Point, FL 33064 (954) 953-4208 | rebuildregenmedical.com
Ready to Start Your Recovery?
Schedule a consultation with Rebuild Regen Medical Clinic in Lighthouse Point, FL.